1. Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma
   Yongpan Sun et al, 2017, Pathology - Research and Practice CrossRef
2. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma
   Wei Liu et al, 2017, J Int Med Res CrossRef
3. Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
   Hao Wang et al, 2018, Clin Epigenet CrossRef
4. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3
   Chao Liu et al, 2018, IUBMB Life CrossRef
5. MicroRNA-145-3p suppresses proliferation and promotes apotosis and autophagy of osteosarcoma cell by targeting HDAC4
   Guangzhi Wu et al, 2018, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
6. Clinically Correlated MicroRNAs in the Diagnosis of Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
   Min Jiang et al, 2018, BioMed Research International CrossRef
7. The correlation of circulating pro-angiogenic miRNAs’ expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer
   Wei Peng et al, 2018, Cancer Med CrossRef
8. Overview upon miR-21 in lung cancer: focus on NSCLC
   Cecilia Bica-Pop et al, 2018, Cell. Mol. Life Sci. CrossRef
9. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance
   Mohammad Askandar Iqbal et al, 2018, Molecular Aspects of Medicine CrossRef
10. Exosome Therapy for Stroke
    Jieli Chen et al, 2018, Stroke CrossRef
11. Upregulated microRNA miR-21 promotes the progression of lung adenocarcinoma through inhibition of KIBRA and the Hippo signaling pathway
    Yunxia An et al, 2018, Biomedicine & Pharmacotherapy CrossRef
12. Association of genetic polymorphisms of miR-145 gene with telomere length in omethoate-exposed workers
    Wei Wang et al, 2019, Ecotoxicology and Environmental Safety CrossRef
13. null
    Chiraz Atri et al, 2019 CrossRef
14. Circulating MicroRNA Biomarkers for Lung Cancer Detection in East Asian Populations
    Haixin Yu et al, 2019, Cancers CrossRef
15. The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients
    Adam Szpechcinski et al, 2019, Cell. Mol. Life Sci. CrossRef
16. Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study
    Weronika Zofia Świtlik et al, 2019, Genetic Testing and Molecular Biomarkers CrossRef
17. Identify Key Genes by Weighted Gene Co-Expression Network Analysis for Lung Adenocarcinoma
    Jichen Xu et al, 2019, Nano LIFE CrossRef
18. Circulating MicroRNAs in Cancer: Potential and Challenge.
    Mengying Cui et al, 2019, Front Genet CrossRef
19. Plasma MicroRNA as a novel diagnostic
    Rafal Szelenberger et al, 2019, Clinica Chimica Acta CrossRef
20. MicroRNA detection at femtomolar concentrations with isothermal amplification and a biological nanopore
    Haolin Zhang et al, 2017, Nanoscale CrossRef
21. Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma
    Michela Bottani et al, 2019, JCM CrossRef
22. null
    Sabrina Müller et al, 2020 CrossRef
23. Low serum miR‐223 expression predicts poor outcome in patients with acute myeloid leukemia
    Guopan Yu et al, 2019, J Clin Lab Anal CrossRef
24. Cancer Simulation from Stage Minus One by Quantum microRNA Language: Lung, Colorectal and Pancreatic Cancers
    , 2019, Med One CrossRef
25. The Translational Status of Cancer Liquid Biopsies
    Sinisa Bratulic et al, 2019, Regen. Eng. Transl. Med. CrossRef
26. A Strong Decrease in TIMP3 Expression Mediated by the Presence of miR-17 and 20a Enables Extracellular Matrix Remodeling in the NSCLC Lesion Surroundings
    Karolina H. Czarnecka et al, 2019, Front. Oncol. CrossRef
27. MicroRNA dysregulation interplay with childhood abdominal tumors
    Karina Bezerra Salomão et al, 2019, Cancer Metastasis Rev CrossRef
28. Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future?
    Rita Lampignano et al, 2020, Molecular Aspects of Medicine CrossRef
29. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non–small cell lung cancer patients
    Sachin Kumar et al, 2020, Current Problems in Cancer CrossRef
30. Liposomal Spherical Nucleic Acid Scaffolded Site-Selective Hybridization of Nanoparticles for Visual Detection of MicroRNAs
    Peng Shen et al, 2020, ACS Appl. Bio Mater. CrossRef
31. Non-coding RNA profile in lung cancer
    Soudeh Ghafouri-Fard et al, 2020, Experimental and Molecular Pathology CrossRef
32. null
    Taruneet Kaur et al, 2020 CrossRef
33. miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis.
    Carmen Elena Condrat et al, 2020, Cells CrossRef
34. Quantitative Detection and Imaging of Multiple Biological Molecules in Living Cells for Cell Screening
    Shan Huang et al, 2020, ACS Sens. CrossRef
35. Knockdown of GINS2 inhibits proliferation and promotes apoptosis through the p53/GADD45A pathway in non-small-cell lung cancer
    Feng Chi et al, 2020 CrossRef
36. Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer’s Biomarkers
    Diego Fernández-Lázaro et al, 2020, Diagnostics CrossRef
37. Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages
    Florian Janke et al, 2020, Cancers CrossRef
38. Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer
    Francesca Moretti et al, 2017, Oncotarget CrossRef
39. A plasma miRNA signature for lung cancer early detection
    Qixin Leng et al, 2017, Oncotarget CrossRef
40. The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers
    Yanlong Yang et al, 2017, Oncotarget CrossRef
41. miR‑210‑3p regulates the proliferation and apoptosis of non‑small cell lung cancer cells by targeting SIN3A
    Jie Ren et al, 2019, Exp Ther Med CrossRef
42. Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysis
    Marcelo Bonomi et al, 2018, Oncol Lett CrossRef
43. Overexpression of miR‑20a promotes the progression of osteosarcoma by directly targeting QKI2
    Hongbo Yang et al, 2019, Oncol Lett CrossRef
44. Serum levels of candidate microRNA diagnostic markers differ among the stages of non‑small‑cell lung cancer
    Toshiko Aiso et al, 2018, Oncol Lett CrossRef
45. The value of microRNA-21 as a biomarker for the prognosis of lung cancer
    Wei Zhang et al, 2020 CrossRef
46. LncRNA SNHG10 is downregulated in non-small cell lung cancer and predicts poor survival
    Meng Liang et al, 2020, BMC Pulm Med CrossRef
47. Circulating microRNA-145 as a diagnostic biomarker for non-small-cell lung cancer: A systemic review and meta-analysis
    Shaohua Tao et al, 2020, Int J Biol Markers CrossRef
48. MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway
    Junlei Han et al, 2020, Mol Cell Biochem CrossRef
49. Association of MicroRNA-21 with p53 at Mutant Sites R175H and R248Q, Clinicopathological Features, and Prognosis of NSCLC
    Yaodong Zhou et al, 2020, Molecular Therapy - Oncolytics CrossRef
50. null
    Faizah Alotaibi, 2021 CrossRef
51. miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer
    Shen Zhong et al, 2020, Translational Research CrossRef
52. Epigenetic regulation of cancer stem cell formation and maintenance.
    Rhiannon French et al, 2021, Int J Cancer CrossRef
53. MicroRNA‐223 in gastrointestinal cancers: A systematic review and diagnostic meta‐analysis
    Amir Hossein Aalami et al, 2020, Eur J Clin Invest CrossRef
54. Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma
    Zhen-bin Diao et al, 2020, J Int Med Res CrossRef
55. Clinical Value Analysis of Serum miR-223 in Predicting Postoperative Infection of Multiple Fractures Patients
    刚刚 王, 2020, ACM CrossRef
56. null
    Pichitpon Chaniad et al, 2017 CrossRef
57. Serum miR-223: A Validated Biomarker for Detection of Early-Stage Non–Small Cell Lung Cancer
    Paola D'Antona et al, 2019, Cancer Epidemiol Biomarkers Prev CrossRef
58. Circular RNA circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microRNA miR-21 and up-regulating phosphatase and tensin homolog expression
    Chuan-Cui Zhang et al, 2021, Bioengineered CrossRef
59. Serum Exosomes and Their miRNA Load—A Potential Biomarker of Lung Cancer
    Mateusz Smolarz et al, 2021, Cancers CrossRef
60. Circulating miR-320a Acts as a Tumor Suppressor and Prognostic Factor in Non-small Cell Lung Cancer
    Akanksha Khandelwal et al, 2021, Front. Oncol. CrossRef
61. MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer
    Jacek Kabzinski et al, 2021, Biomolecules CrossRef
62. null
    Mehmet Evren Okur et al, 2021 CrossRef
63. Upregulation of microRNA-223 expression in gingival crevicular blood of women with gestational diabetes mellitus and periodontitis
    Teerat Sawangpanyangkura et al, 2021, Journal of Dental Sciences CrossRef
64. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA
    Susana Junqueira-Neto et al, 2019, Acta Cytologica CrossRef
65. null
    Priya Mondal et al, 2022 CrossRef
66. High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer
    Minhan Yi et al, 2021, Annals of Medicine CrossRef
67. Precision Oncology, Signaling, and Anticancer Agents in Cancer Therapeutics
    Dia Advani et al, 2022, ACAMC CrossRef
68. The Value of Serum Exosomal miR-184 in the Diagnosis of NSCLC
    Shujun Li et al, 2022, Journal of Healthcare Engineering CrossRef
69. MicroRNA-21 as a diagnostic and prognostic biomarker of lung cancer: a systematic review and meta-analysis
    Wei Wang et al, 2022 CrossRef
70. Early detection of lung cancer via biointerference-free, target microRNA-triggered core–satellite nanocomposites
    Cairou Chen et al, 2022, Nanoscale CrossRef
71. Identification of four serum miRNAs as potential markers to screen for thirteen cancer types
    Joe W. Chen et al, 2022, PLoS ONE CrossRef
72. Orthologs of human circulating miRNAs associated with hepatocellular carcinoma are elevated in mouse plasma months before tumour detection
    Liang-Hao Ding et al, 2022, Sci Rep CrossRef
73. Identification of MiRNA–Disease Associations Based on Information of Multi-Module and Meta-Path
    Zihao Li et al, 2022, Molecules CrossRef
74. Prospects for miR-21 as a Target in the Treatment of Lung Diseases
    Yan Ding et al, 2021, CPD CrossRef
75. Contributions of Circulating microRNAs for Early Detection of Lung Cancer
    Jody Vykoukal et al, 2022, Cancers CrossRef
76. CircRNAs in Tumor Radioresistance
    Yining Gao et al, 2022, Biomolecules CrossRef